Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Prostatic Neoplasms 2Urinary Bladder Neoplasms 1Rectal Neoplasms 1Ovarian Neoplasms 1Kidney Neoplasms 1Endometrial Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Breast Neoplasms 1

Interventions

pembrolizumab 6sargramostim 5Psychiatric Rehabilitation 5Early Intervention, Educational 5Magnetic Resonance Spectroscopy 4Gemcitabine 4Cyclophosphamide 4palbociclib 3Trastuzumab 3Therapeutics 3Standard of Care 3Radiotherapy 3Oxaliplatin 3Methods 3Irinotecan 3Interferon-alpha 3Fluorouracil 3Fluorodeoxyglucose F18 3Erlotinib Hydrochloride 3Docetaxel 3Bortezomib 3temsirolimus 2motexafin gadolinium 2entinostat 2cemiplimab 2cediranib 2Specimen Handling 2Radiosurgery 2Practice Guidelines as Topic 2Paclitaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colonic Neoplasms × Health Promotion × Genitourinary × Clear all
NCT05056077 2026-06-02

TTBF

University of California, San Francisco

Phase NA Active not recruiting
353 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡